Associated Papers
Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
Rodieux F et al.
Journal of Clinical Pharmacology, 2016
Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.
Ieiri I et al.
Expert Opinion on Drug Metabolism & Toxicology, 2006
Implications of genetic polymorphisms in drug transporters for pharmacotherapy.
Kerb R
Cancer Letters, 2006
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY et al.
Clinical Pharmacology and Therapeutics, 2004
The MDR1 (ABCB1) gene polymorphism and its clinical implications.
Ieiri I et al.
Clinical Pharmacokinetics, 2004
MDR1 genotype-related pharmacokinetics and pharmacodynamics.
Sakaeda T et al.
Biological & Pharmaceutical Bulletin, 2002
Select a paper to view details